Crawley, United Kingdom

Mark Alexander Furth

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mark Alexander Furth: Innovator in Radiotherapy Technology

Introduction

Mark Alexander Furth is a notable inventor based in Crawley, GB. He has made significant contributions to the field of radiotherapy through his innovative designs and patents. With a total of 2 patents, Furth has focused on enhancing the functionality and precision of radiotherapy apparatus.

Latest Patents

Furth's latest patents include advancements in multi-leaf collimators (MLCs). The first patent describes a multi-leaf collimator that features an array of laterally-spaced elongate leaves. Each leaf is driven by an associated motor connected via a drive means, allowing for precise extension and retraction. The design includes a sub-frame that supports a subset of the motors, which are strategically mounted to optimize performance.

The second patent also pertains to multi-leaf collimators, detailing a system where a plurality of elongate leaves are mounted in a carriage. This carriage is movable relative to a substrate, with leaves that can independently move in a longitudinal direction. A control apparatus is integrated to manage the positions of the leaves and the carriage, ensuring accurate alignment during treatment.

Career Highlights

Mark Alexander Furth is currently associated with Elekta AB, a company renowned for its innovative solutions in cancer care. His work at Elekta has allowed him to contribute to the development of advanced radiotherapy technologies that improve patient outcomes.

Collaborations

Furth has collaborated with notable colleagues such as Adrian Maxwell Smith and Martin Broad. Their combined expertise has fostered a collaborative environment that drives innovation in the field of radiotherapy.

Conclusion

Mark Alexander Furth's contributions to radiotherapy technology through his patents and work at Elekta AB highlight his commitment to improving cancer treatment. His innovative designs in multi-leaf collimators are paving the way for more effective and precise radiotherapy solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…